Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 14/20 | 0.78 |
| ▸ | RAB9A | P51151 | 14/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.78 |
| ▸ | HPGD | P15428 | 4/20 | 0.78 |
| ▸ | POLB | P06746 | 2/20 | 0.78 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.78 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.78 |
| ▸ | RELA | Q04206 | 2/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.77 |
| ▸ | MAPT | P10636 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 2/20 | 0.77 |
| ▸ | GAA | P10253 | 1/20 | 0.77 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13143834 | 0.93 | NPC1 (0.69) | NPC1RAB9ASMN1; SMN2HPGDPOLB | |
| SCHEMBL12634931 | 0.92 | NPC1 (0.83) | NPC1RAB9ASMN1; SMN2HPGDPOLB | |
| SCHEMBL12918681 | 0.90 | NPC1 (0.73) | NPC1RAB9ASMN1; SMN2HPGDPOLB | |
| SCHEMBL12309409 | 0.88 | NPC1 (0.63) | NPC1RAB9ASMN1; SMN2HPGDPOLB | |
| SCHEMBL13324414 | 0.88 | NPC1 (0.63) | NPC1RAB9ASMN1; SMN2HPGDPOLB | |
| SCHEMBL762284 | 0.88 | NPC1 (1.00) | NPC1RAB9ASMN1; SMN2HPGDPOLB | |
| SCHEMBL14818889 | 0.88 | NPC1 (1.00) | NPC1RAB9ASMN1; SMN2HPGDPOLB | |
| SCHEMBL12354772 | 0.88 | NPC1 (0.70) | NPC1RAB9ASMN1; SMN2HPGDPOLB | |
| SCHEMBL120253 | 0.87 | NPC1 (0.83) | NPC1RAB9ASMN1; SMN2HPGDPOLB | |
| SCHEMBL6015198 | 0.87 | NPC1 (0.83) | NPC1RAB9ASMN1; SMN2HPGDPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4207325-A1 | DISPLAY DEVICE AND MANUFACTURING METHOD THEREFOR | BOE Technology Group Co., Ltd. (CN) | 2023-07-05 | — | — | EP | disclosed |
| US-7629060-B2 | Liquid crystal cells; durability, stability; brightness ; containing carbazole compound | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-12-08 | — | — | US | disclosed |
| US-7374829-B2 | Organic electroluminescent element and full color display | KONICA CORPORATION (JP) | 2008-05-20 | — | — | US | disclosed |
| US-7348063-B2 | Film substrate and its manufacturing method | KONICA CORPORATION (JP) | 2008-03-25 | — | — | US | disclosed |
| US-20070257603-A1 | FLUORENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070257603-A1 | FLUORENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | FLI1, AFF2, AFF1 | NPC1 712/4885RAB9A 544/4885SMN1; SMN2 3017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.